Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Zilina – page 2

51 clinical trials in Zilina, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Zilina at a glance
51
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

51 trials in Zilina

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Astellas Pharma Global Development Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Crd-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Zilina

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular disease treatments, including studies evaluating medications for hypertriglyceridemia and atherosclerosis prevention.

  • Heart failure management
  • Lipid-lowering therapies
  • Stroke prevention

Multiple studies are investigating novel approaches to reduce major cardiovascular events and improve patient outcomes.

02 Respiratory Medicine

Comprehensive research into asthma treatments, particularly focusing on patients with uncontrolled symptoms despite current therapy.

  • Severe asthma management
  • New inhaler formulations
  • Exacerbation prevention

Studies aim to evaluate innovative therapeutic combinations and delivery systems.

03 Ophthalmology Studies

Advanced research in macular degeneration treatments, including both wet AMD and geographic atrophy.

  • Novel therapeutic agents
  • Comparative treatment studies
  • Visual acuity preservation

Trials focus on developing effective treatments to prevent vision loss and disease progression.

04 Metabolic Disorders

Studies examining treatments for Type 2 Diabetes and related metabolic conditions.

  • Diabetes management
  • Cardiovascular outcomes
  • Diabetic retinopathy

Research aims to improve glycemic control and reduce diabetes-related complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.